Keywords: astrazeneca, launches, pulmicort, respules, launched, budesonide, inhalationsuspension
AstraZeneca launches Pulmicort Respules
Article | 10 October 2000
AstraZeneca has launched Pulmicort Respules (budesonide inhalationsuspension) onto the US market for the treatment of asthma in childen aged 12 months ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
